Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

Key drugs lift Schering's profit 17%

Article Abstract:

Schering AG of Germany posted a 17 percent increase in net profit to 139 million Euros in the fourth quarter up from 119 million Euros last year. Good financial performance was due to strong sales of contraceptives and multiple-sclerosis treatments. The pharmaceutical company is to buyback shares worth 500 million Euros ($600 million), the biggest share buyback on record.

Author: Schrimpf, Gangolf
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2006
Securities issued, listed, Securities, Company securities

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Bayer posts surge in profit

Article Abstract:

Bayer AG of Germany posted a net profit surge to a third quarter gain of 49.3 million Euros ($580.8 million) up from 52 million Euros a year earlier. Revenue increased from consumer care and plastics units and a seven percent increase in product prices. Financial projections from the year increased sharply.

Author: Schrimpf, Gangolf
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2005
Bayer AG, BAYZY

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Germany's Schering posts a 29% increase in earnings

Article Abstract:

Schering AG of Germany posted a 29 percent increase of 160 million Euros ($191.2 million) in net profit. Sales for the pharmaceutical company were buoyed by high sales of the birth-control pill and lower operating costs. Sales were up ten percent to 1.36 billion Euros.

Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2005

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Germany, Pharmaceutical industry, Company sales and earnings, Company earnings/profit, Company Profile, Schering AG
Similar abstracts:
  • Abstracts: High-tech researcher is 'super-silent'. New policies to sustain stocks. Australian prawn stocks rebuilding
  • Abstracts: Record catch gets speedy lift. Ship orders spree boosts Nor-Fishing. Yard wins big ship orders
  • Abstracts: Beat-the-heat foods that bring out your sunny side. Sweet sensations. Sublime summer sweets
  • Abstracts: Ericsson's net increases 22% on Telecom network upgrades. Ericsson's profit increases 52%, but margin falls. Ericsson's net falls slightly despite 24% growth in sales
  • Abstracts: Palmolive Thermal Spa Hydrating Body Wash. Poder 5 Ultra Detergente en Polvo
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.